Skip to main content

Day: May 13, 2024

Nayax Announces a Strategic Partnership with Slovakia’s ASO Vending

HERZLIYA, Israel, May 13, 2024 (GLOBE NEWSWIRE) — Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement payments and loyalty platform designed to help merchants scale their business, today announced a strategic partnership with Slovakia’s ASO Vending, the country’s largest vending machine operator. This partnership will include the installation of thousands of Nayax’s Onyx contactless card readers on vending machines throughout the country over the next few years, more than doubling Nayax’s active devices in Slovakia. These devices will be purchased via Nayax Capital, Nayax’s embedded financing solution, allowing ASO Vending to deploy them while maintaining healthy cash flow. Nayax devices will be supported by Jimark, Nayax’s approved Distributor in Slovakia and the Czech Republic. “We...

Continue reading

2024 Q1 Revenue Report

Revenue up +3.8% in Q1 2024 to €265.0 million Continued strong growth in the Benelux Energy transition-related activities confirmed as a powerful growth driver Continued rebalancing of the business mix in France Temporary impact from the situation in Italy, currently being normalized. Q1 growth excluding Italy: +6.7% Reaffirming 2024 targets:– Continued revenue growth, at a higher rate compared to Q1, with significantly improved visibility in Italy and in Belgium, and the announced acceleration of growth in Germany– Continued improvement in adjusted EBITDA marginIn millions of euros Q1 2024 Q1 2023 Var. %  Revenue 265,0 255,3 +3.8%  o/w Benelux 100,7 82,8 +21.6%  o/w France 97,9 101,6 -3.7%  o/w Other Countries 66,5 70,8 -6.2%  Gianbeppi Fortis, Chief Executive Officer of Solutions30, stated:...

Continue reading

Tonner Drones Exits Last Variable Pricing Instrument

Tonner Drones Exits Last Variable Pricing Instrument Cannes, 13 May 2024 18:00 Tonner Drones (“Tonner Drones” or the “Company”) is pleased to announce that it has reached an agreement with the holders of the Fiducie A trust to end the Company’s last variable pricing instrument.Agreement to terminate the Company’s last remaining variable pricing instrument Reduction of potential dilution, estimated to be between 15% and 20% Reduction of overall debt by an estimation of more than €1M Company expects a book profit from repurchasing the Fiducie A debt at a discount New selling restrictions imposed on Fiducie A to reduce their influence on the share price New bonds, with fixed conversion price, are being negotiated with new investors to finance cash payments to Fiducie A Company management likely to take part in the transaction to end variable...

Continue reading

Premier Graphene, Inc., formerly Premier Biomedical Inc. (OTC: BIEI), announces major news in Mexico with our friends at HGI Industrial Technologies S.A de P.I and an advancement in its Graphene Enhanced Concrete

HGI Industrial Technologies, a company with a strategic agreement with Premier Graphene Inc., has secured one of only three commercial permits for industrial hemp cultivation in Mexico. Test results are outstanding – revealing the material to be stronger, lighter, and faster to process, leading to the production of a superior end product. This marks a significant step in bringing disruptive technology to the construction industry IMPERIAL VALLEY, Calif., May 13, 2024 (GLOBE NEWSWIRE) — Premier Graphene Inc. (OTC: BIEI), in conjunction with HGI Industrial Technologies LLC, which has now acquired the third commercial industrial hemp license in Mexico, is embracing the native resources of Mexico and the United States in the research and production of unique graphene-based products to satisfy massive consumer needs ranging from...

Continue reading

Capital Power considers Hybrid Subordinated Notes offering

EDMONTON, Alberta, May 13, 2024 (GLOBE NEWSWIRE) — Capital Power Corporation (“Capital Power” or the “Company”) (TSX:CPX) announced today that it is considering an offering of hybrid subordinated debt securities (the “Notes”) in Canada under its short form base shelf prospectus dated June 10, 2022. If a successful offering is priced and completed, the Company intends to allocate an amount equal to the net proceeds from the sale of the Notes to repay certain amounts drawn on the Company’s credit facilities (which include amounts drawn for the acquisition of a 50% interest in New Harquahala Generating Company, LLC, and a 100% interest in CXA La Paloma, LLC, and related expenses, development purposes and in respect of ongoing operations), to potentially redeem all of the Company’s outstanding Cumulative Minimum Rate Reset Preferred...

Continue reading

BIC: Disclosure of total number of voting rights and number of shares forming the capital as of April 30, 2024

Disclosure of total number of voting rights andnumber of shares forming the capitalas of April 30, 2024 CLICHY – May 13, 2024 Article L 233-8-II of the French “Code de Commerce” and Article 223-16 of the General Regulations of the French “Autorité des Marchés Financiers”. As of April 30, 2024, the total number of issued shares of SOCIÉTÉ BIC is 42,270,689 shares, representing:62,763,490 voting rights, 62,288,258 voting rights excluding shares without voting rightsABOUT BIC A world leader in stationery, lighters and shavers, BIC brings simplicity and joy to everyday Life. For more than 75 years, the Company has honored the tradition of providing high-quality, affordable, essential products to consumers everywhere. Through this unwavering dedication, BIC has become one of the most recognized brands and is a trademark registered worldwide....

Continue reading

Novo Nordisk A/S: Once-weekly and once-monthly Mim8 demonstrate superior reduction of treated bleeding episodes compared to on-demand and prior prophylaxis treatment in people with haemophilia A in the Frontier 2 trial

Bagsværd, Denmark, 13 May 2024 – Novo Nordisk today announced the headline results from the FRONTIER 2 trial, a pivotal phase 3a, 26-week open-label, randomised, controlled, multi-arm trial in 254 people. The trial investigated the efficacy and safety of once-weekly and once-monthly subcutaneous Mim8 versus no prophylaxis and versus prior coagulation factor prophylaxis treatment in people aged 12 years or older with haemophilia A with or without inhibitors. The trial achieved its co-primary endpoints by demonstrating a statistically significant and superior reduction of treated bleeding episodes with both once-weekly and once-monthly Mim8 versus no prophylaxis treatment and prior coagulation factor prophylaxis treatment. In people with no prior prophylaxis treatment, once-weekly and once-monthly Mim8 demonstrated superior reductions of...

Continue reading

Pennant Group to Participate in the 2024 RBC Global Healthcare Conference

EAGLE, Idaho, May 13, 2024 (GLOBE NEWSWIRE) — The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it will participate in the upcoming 2024 RBC Global Healthcare Conference on May 14-15, 2024. Brent Guerisoli, Chief Executive Officer, Lynette Walbom, Chief Financial Officer, and John Gochnour, President and Chief Operating Officer, will participate in a fireside chat on May 15, 2024 at 9:30 a.m. Eastern Time. A live webcast of the event will be accessible at https://www.veracast.com/webcasts/rbc/healthcare2024/uP37i8.cfm. About Pennant: The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through 112 home health and hospice agencies and 53 senior living communities...

Continue reading

ARGAN: S&P strengthened ARGAN’s “Investment Grade” status with a “Stable” outlook for its “BBB-” rating

Press release – Neuilly-sur-Seine, Monday, May 13, 2024 – 5.45 pm S&P strengthened ARGAN’s “Investment Grade” status with a “Stable” outlook for its “BBB-” rating ARGAN, the only French real estate company specializing in the DEVELOPMENT & RENTAL OF PREMIUM WAREHOUSES listed on EURONEXT and leading player of its market, announced that the outlook on its “BBB-” long-term issuer credit rating was raised to “Stable” by S&P Global Ratings. S&P Global Ratings raised the outlook on ARGAN’s “BBB-” from “Negative” to “Stable”. This credit rating update comes after ARGAN successfully led a capital increase in the amount of €150 million1, which was launched and finalized on April 23, as part a move to strengthen our development and debt reduction plan. In its report, S&P Global Ratings stressed more particularly:the...

Continue reading

LACROIX : First-quarter 2024 revenue of €186.3 million (-4.4%), marked by a high comparative base for Electronics and continued strong momentum for City and Environment divisions.

13/05/2024 First-quarter 2024 revenue of €186.3 million (-4.4%), marked by a high comparative base for Electronics and continued strong momentum for City and Environment divisions Sales and profitability targets for 2024 confirmedRevenue in millions of euros Q1 2024 Q1 2023 Change  Electronics activity 138,4 152,5 -9,2%City activity 26,0 23,3 +11,5%Environment activity 21,8 18,9 +15,4%Total 186,3 194,8 -4,4%Excl. Road Signs Segment (sold April 30, 2024) 174,2 182,7 -4,7%First quarter in line with expectations As of March 31, 2024, LACROIX posted a revenue of €186.3 million, compared with €194.8 million a year earlier. As a reminder, revenue had risen by 17.9% in the first quarter of 2023, driven by a strong recovery for the Electronics division following a period of disruption to component supplies. On this highly...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.